Aneurysm wall cellularity affects healing after coil embolization: assessment in a rat saccular aneurysm model.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 30 07 2019
revised: 27 10 2019
accepted: 29 10 2019
pubmed: 25 12 2019
medline: 29 9 2020
entrez: 25 12 2019
Statut: ppublish

Résumé

Despite significant technical advances, recanalization rates after endovascular therapy of ruptured intracranial aneurysms (IAs) remain a clinical challenge. A histopathological hallmark of ruptured human IA walls is mural cell loss. Mural smooth muscle cells (SMCs) are known to promote intraluminal healing in thrombosed experimental aneurysms. In this rat model we assess the natural history and healing process after coil embolization in SMC-rich and decellularized aneurysms. Saccular aneurysms were created by end-to-side anastomosis of an arterial graft from the descending thoracic aorta of a syngeneic donor rat to the infrarenal abdominal aorta of recipient male Wistar rats. Untreated arterial grafts were immediately transplanted, whereas aneurysms with loss of mural cells were chemically decellularized before implantation. Aneurysms underwent coil implantation during aneurysm anastomosis. Animals were randomly assigned either to the non-decellularized or decellularized group and underwent macroscopic and histological analyses on days 3, 7, 21, or 90 post-coil implantation. A total of 55 rats underwent macroscopic and histologic analysis. After coil embolization, aneurysms with SMC-rich walls showed a linear course of thrombosis and neointima formation whereas decellularized aneurysms showed marked inflammatory wall degeneration with increased recanalization rates 21 days (p=0.002) and 90 days (p=0.037) later. The SMCs showed the ability to actively migrate into the intra-aneurysmal thrombus and participate in thrombus organization. Coil embolization of aneurysms with highly degenerated walls is prone to further wall degeneration, increased inflammation, and recanalization compared with aneurysms with vital SMC-rich walls.

Sections du résumé

BACKGROUND AND PURPOSE OBJECTIVE
Despite significant technical advances, recanalization rates after endovascular therapy of ruptured intracranial aneurysms (IAs) remain a clinical challenge. A histopathological hallmark of ruptured human IA walls is mural cell loss. Mural smooth muscle cells (SMCs) are known to promote intraluminal healing in thrombosed experimental aneurysms. In this rat model we assess the natural history and healing process after coil embolization in SMC-rich and decellularized aneurysms.
METHODS METHODS
Saccular aneurysms were created by end-to-side anastomosis of an arterial graft from the descending thoracic aorta of a syngeneic donor rat to the infrarenal abdominal aorta of recipient male Wistar rats. Untreated arterial grafts were immediately transplanted, whereas aneurysms with loss of mural cells were chemically decellularized before implantation. Aneurysms underwent coil implantation during aneurysm anastomosis. Animals were randomly assigned either to the non-decellularized or decellularized group and underwent macroscopic and histological analyses on days 3, 7, 21, or 90 post-coil implantation.
RESULTS RESULTS
A total of 55 rats underwent macroscopic and histologic analysis. After coil embolization, aneurysms with SMC-rich walls showed a linear course of thrombosis and neointima formation whereas decellularized aneurysms showed marked inflammatory wall degeneration with increased recanalization rates 21 days (p=0.002) and 90 days (p=0.037) later. The SMCs showed the ability to actively migrate into the intra-aneurysmal thrombus and participate in thrombus organization.
CONCLUSIONS CONCLUSIONS
Coil embolization of aneurysms with highly degenerated walls is prone to further wall degeneration, increased inflammation, and recanalization compared with aneurysms with vital SMC-rich walls.

Identifiants

pubmed: 31871070
pii: neurintsurg-2019-015335
doi: 10.1136/neurintsurg-2019-015335
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

621-625

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Edin Nevzati (E)

Department for Biomedical Research (DBMR), University of Bern, Cerebrovascular Research Group, Bern, Switzerland edin.nevzati@gmail.com.

Jeannine Rey (J)

Department for Biomedical Research (DBMR), University of Bern, Cerebrovascular Research Group, Bern, Switzerland.

Daniel Coluccia (D)

Department for Biomedical Research (DBMR), University of Bern, Cerebrovascular Research Group, Bern, Switzerland.

Basil Erwin Grüter (BE)

Department for Biomedical Research (DBMR), University of Bern, Cerebrovascular Research Group, Bern, Switzerland.
Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Stefan Wanderer (S)

Department for Biomedical Research (DBMR), University of Bern, Cerebrovascular Research Group, Bern, Switzerland.
Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Michael vonGunten (M)

Institute of Pathology Laenggasse, Ittigen, Switzerland.

Luca Remonda (L)

Division of Neuroradiology, Department of Radiology, Kantonsspital Aarau, Aarau, Switzerland.

Juhana Frosen (J)

Hemorrhagic Brain Pathology Research Group, Kuopio University Hospital, Kuopio, Finland.

Hans Rudolf Widmer (HR)

Neurocenter and Regenerative Neuroscience Cluster, Inselspital, University Hospital and University of Bern, Bern, Switzerland.

Javier Fandino (J)

Department for Biomedical Research (DBMR), University of Bern, Cerebrovascular Research Group, Bern, Switzerland.
Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Serge Marbacher (S)

Department for Biomedical Research (DBMR), University of Bern, Cerebrovascular Research Group, Bern, Switzerland.
Department of Neurosurgery, Kantonsspital Aarau, Aarau, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH